Senior insider sale
Chief Strategy Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$116.2K
12.23K shares
What this filing means
NAYAK SANJAY plans to sell 12.23K shares of OCULAR THERAPEUTIX, INC valued at approximately $116.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/12/2026ACC: 0001950047-26-001203
Officer· Chief Strategy Officer
Since Feb 2026
12.23K
Shares to sell
$116.2K
Approx. market value
10.35K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
2/11/2026
10.35KTotal acquired10.35K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/11/2026 | Restricted stock vesting under a registered plan Not Applicable | 10.35K | — |
| Total | 10.35K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.88K
Market value
$22.6K
11/24/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
10.35K
Market value
$93.6K
2/12/2026
Total
Units
12.23K
Value
$116.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/24/2025 | 1.88K | $22.6K | — | Completed |
| Planned — Approximate Date | ||||
2/12/2026 | 10.35K | $93.6K | NASDAQ | Planned |
| Total | 12.23K | $116.2K | ||